BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7747758)

  • 1. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
    Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
    Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variability in monozygotic twins with neurofibromatosis 2.
    Baser ME; Ragge NK; Riccardi VM; Janus T; Gantz B; Pulst SM
    Am J Med Genet; 1996 Sep; 64(4):563-7. PubMed ID: 8870923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas.
    Neary WJ; Newton VE; Laoide-Kemp SN; Ramsden RT; Griffith G; Evans DG; Harris R; Strachan T
    J Laryngol Otol; 1996 Jul; 110(7):634-40. PubMed ID: 8759535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
    Kluwe L; MacCollin M; Tatagiba M; Thomas S; Hazim W; Haase W; Mautner VF
    Am J Med Genet; 1998 May; 77(3):228-33. PubMed ID: 9605590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis 2 in the pediatric age group.
    Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
    Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
    Bosch MM; Boltshauser E; Harpes P; Landau K
    Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
    Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
    Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin abnormalities in neurofibromatosis 2.
    Mautner VF; Lindenau M; Baser ME; Kluwe L; Gottschalk J
    Arch Dermatol; 1997 Dec; 133(12):1539-43. PubMed ID: 9420538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of early onset neurofibromatosis type 2.
    Matsuo M; Ohno K; Ohtsuka F
    Brain Dev; 2014 Feb; 36(2):148-52. PubMed ID: 23414620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
    Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
    Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
    Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
    Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
    Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
    Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ocular presentation of neurofibromatosis 2.
    Ragge NK; Baser ME; Riccardi VM; Falk RE
    Eye (Lond); 1997; 11 ( Pt 1)():12-8. PubMed ID: 9246269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point mutation associated with a severe phenotype of neurofibromatosis 2.
    MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
    Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis.
    Roos KL; Muckway M
    Dermatol Clin; 1995 Jan; 13(1):105-11. PubMed ID: 7712636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.